In gefitinib-sensitive NSCLC cells, gefitinib-restrained p-Akt and p-ERK levels were abrogated by HDGF overexpression; however, in resistant H1975 cells, the activation of Akt and ERK was strongly suppressed by HDGF depletion. This evidence concerns the gene HDGF and non-small cell lung carcinoma.